{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:08:55Z","timestamp":1749010135196,"version":"3.41.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"DOI":"10.7759\/cureus.85263","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:56:26Z","timestamp":1748930186000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Diabetes With a Rare Variant of Familial Combined Hyperlipidemia With an Atypical Phenotype"],"prefix":"10.7759","author":[{"given":"Karishma","family":"Bhade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimisha","family":"Dange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaman","family":"Khadilkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Khadilkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.11.032","article-title":"Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia","volume":"340","author":"Trinder M","year":"2022","unstructured":"Trinder M, Vikulova D, Pimstone S, Mancini GB, Brunham LR. Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia. Atherosclerosis. 2022, 340:35-43. 10.1016\/j.atherosclerosis.2021.11.032","journal-title":"Atherosclerosis"},{"key":"ref2","article-title":"Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date","volume":"3","author":"Gaddi A","year":"2007","unstructured":"Gaddi A, Cicero AF, Odoo FO, Poli AA, Paoletti R. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. Vasc Health Risk Manag. 2007, 3:877-86.","journal-title":"Vasc Health Risk Manag"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/hq0202.104059","article-title":"Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study","volume":"22","author":"Veerkamp MJ","year":"2002","unstructured":"Veerkamp MJ, de Graaf J, Bredie SJ, Hendriks JC, Demacker PN, Stalenhoef AF. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002, 22:274-82. 10.1161\/hq0202.104059","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28311","article-title":"Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review","volume":"120","author":"Taghizadeh E","year":"2019","unstructured":"Taghizadeh E, Mardani R, Rostami D, Taghizadeh H, Bazireh H, Hayat SM. Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review. J Cell Biochem. 2019, 120:8891-8. 10.1002\/jcb.28311","journal-title":"J Cell Biochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz JM","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014, 11:361-2. 10.1038\/nmeth.2890","journal-title":"Nat Methods"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050016120","article-title":"Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer","volume":"11","author":"Liu G","year":"2000","unstructured":"Liu G, Ashbourne Excoffon KJ, Wilson JE, et al.. Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer. Hum Gene Ther. 2000, 11:21-32. 10.1089\/10430340050016120","journal-title":"Hum Gene Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757886","article-title":"LPL gene mutation in type 1 familial triglyceridemia presenting as recurrent pancreatitis and complicated by COVID19","volume":"13","author":"Kesavelu D","year":"2024","unstructured":"Kesavelu D, Valliyappan S, Nalliannan S, Pande P, Mahalingam S. LPL gene mutation in type 1 familial triglyceridemia presenting as recurrent pancreatitis and complicated by COVID19. J Pediatr Genet. 2024, 13:326-9. 10.1055\/s-0042-1757886","journal-title":"J Pediatr Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02875-x","article-title":"Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases","volume":"21","author":"Wu YQ","year":"2021","unstructured":"Wu YQ, Hu YY, Li GN. Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases. BMC Pediatr. 2021, 21:414. 10.1186\/s12887-021-02875-x","journal-title":"BMC Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers MC","year":"2012","unstructured":"Brouwers MC, van Greevenbroek MM, Stehouwer CD, de Graaf J, Stalenhoef AF. The genetics of familial combined hyperlipidaemia. Nat Rev Endocrinol. 2012, 8:352-62. 10.1038\/nrendo.2012.15","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32833ea9ec","article-title":"Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus","volume":"21","author":"Brouwers MC","year":"2010","unstructured":"Brouwers MC, de Graaf J, van Greevenbroek MM, Schaper N, Stehouwer CD, Stalenhoef AF. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus. Curr Opin Lipidol. 2010, 21:530-8. 10.1097\/MOL.0b013e32833ea9ec","journal-title":"Curr Opin Lipidol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature10426","article-title":"Dynamics of human adipose lipid turnover in health and metabolic disease","volume":"478","author":"Arner P","year":"2011","unstructured":"Arner P, Bernard S, Salehpour M, et al.. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature. 2011, 478:110-3. 10.1038\/nature10426","journal-title":"Nature"},{"key":"ref12","article-title":"Adipose tissue metabolism and genetic obesity: the LPL hypothesis","volume":"5","author":"Greenwood MR","year":"1981","unstructured":"Greenwood MR, Cleary M, Steingrimsdottir L, Vasselli JR. Adipose tissue metabolism and genetic obesity: the LPL hypothesis. International Journal of Obesity. 1981, 5:718.","journal-title":"International Journal of Obesity"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801506","article-title":"The role of lipoprotein lipase in adipose tissue development and metabolism","volume":"24","author":"Zechner R","year":"2000","unstructured":"Zechner R, Strauss J, Frank S, et al.. The role of lipoprotein lipase in adipose tissue development and metabolism. Int J Obes Relat Metab Disord. 2000, 24:S53-6. 10.1038\/sj.ijo.0801506","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.21.12518","article-title":"COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity","volume":"270","author":"Coleman T","year":"1995","unstructured":"Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem. 1995, 270:12518-25. 10.1074\/jbc.270.21.12518","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118319","article-title":"Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes","volume":"96","author":"Weinstock PH","year":"1995","unstructured":"Weinstock PH, Bisgaier CL, Aalto-Set\u00e4l\u00e4 K, et al.. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest. 1995, 96:2555-68. 10.1172\/JCI118319","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369301-a-case-of-diabetes-with-a-rare-variant-of-familial-combined-hyperlipidemia-with-an-atypical-phenotype","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:56:27Z","timestamp":1748930187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369301-a-case-of-diabetes-with-a-rare-variant-of-familial-combined-hyperlipidemia-with-an-atypical-phenotype"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.85263","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}